Asthma Clinical Trial
Official title:
Asthma in a Decentralized Patient Population: Is Traditional Disease Management Enough? A Randomized, Controlled Trial Comparing Traditional Care to Two Systems of Disease Management for a Decentralized Population of Patients in South Texas
This is a health services demonstration project that evaluates three methods of health care
delivery for the management of individuals with symptoms of asthma. This study will evaluate
the impact of a telephonic asthma disease management process, with and without a home
intervention program, on preventing asthma-related morbidity through patient/family asthma
education.
The investigators' central thesis is that comprehensive clinical disease management
protocols for the management of asthma will improve clinical outcomes; reduce fiscal
resource consumption; and improve both patient satisfaction and patient quality of life.
Additionally, individualized, in-home patient education and environmental assessment, when
added to the telephonic protocol, will further improve these measures. However, incremental
improvement will vary according to the population's access to care.
This trial addresses the real-world concerns of asthma management through a disease
management approach that will assist both the patient and the primary care physician by
providing education, additional outpatient resources and additional access to health care
personnel. This approach will stress empowering the patient to participate in his or her own
health care at a higher level, which, in the case of asthma, is critical to wellness.
In a cooperative network of San Antonio medical centers, civilian and military, with a
collective mission to care for military beneficiaries and the underserved patients of South
Texas, this trial will evaluate the clinical benefits, as well as the cost savings, of a
chronic disease management intervention in asthma. This study will fill a conspicuous gap in
the medical literature by addressing the effectiveness of disease management through a
large, decentralized, randomized, controlled trial.
DISEASE MANAGEMENT INTERVENTION
The project will use asthma disease management protocols and educational materials developed
by the National Jewish Medical and Research Center. The program will be fully available in
both English and Spanish, allowing a direct test of its impact on the State's vulnerable
Hispanic population. Based on the principles of comprehensive disease management, National
Jewish Medical and Research Center has developed a disease management program for asthma
(DMP: Asthma) which addresses continuity of care by integrating traditional treatment
methods with a program that focuses on creating a stronger partnership between the patient
and the healthcare team, as well as greater patient empowerment. The primary program goal is
empowering patients with the tools and resources they need for better self management of
their prescribed treatment regimens and control of their environment. The program
incorporates practice guidelines outlined by the National Heart, Lung, and Blood Institute
(NHLBI) at the National Institutes of Health (NIH).
HOME VISIT INTERVENTION
In addition, the demonstration will evaluate the addition of a home-based disease management
protocol focusing on patient education, to test for incremental improvement. Patients will
be taught about their disease (symptoms, treatment, appropriate action plans), as well as
about the healthcare system (how and when to access it). Based on the principles of
comprehensive disease management and the unique needs of South Texas residents, the South
Texas Asthma Management Program (STAMP) is designed for a diverse, mobile, underserved
patient population. The protocol delivers up-front home-based education and environmental
assessment, with follow-up visits focused on reinforcement of the earlier messages. The
program ensures access to a primary care provider for patients who lack this critical member
of the healthcare team. It also provides multiple resources for social services and guidance
in appropriately accessing the healthcare system. The goal of the program is to equip
patients, who have barriers to access due to a number of factors (lack of phone, language,
remote location, etc), to navigate the healthcare system and effectively receive the care
they need.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|